Prognosis is very poor, with only 37% of treated patients surviving one year or more. Topotecan has been studied in the treatment of brainstem glioma, otherwise, chemotherapy is probably ineffective, though further study is needed.
Brain stem tumor
Brainstem glioma
Brain metastasis
Brain tumor
Chiasmal syndrome
Central nervous system tumor
Basal ganglia disease
Spinal tumor